Literature DB >> 1916091

Structure and function of A1 adenosine receptors.

J Linden1.   

Abstract

The A1 adenosine receptor is the best characterized of the widely distributed purinergic receptor family. The purified brain A1 receptor is a monomeric 35- to 36-kDa glycoprotein. A1 receptors can be clearly distinguished from A2 adenosine receptors on the basis of structure activity relationships with selective ligands. Recent structure activity data suggest that subtypes of A1 (A1a, A1b, and A3) and A2 (A2a and A2b) receptors may exist. A1 receptor-mediated responses are coupled via multiple pertussis toxin-sensitive GTP binding proteins (G proteins) to many different effectors in various tissues: adenylate cyclase, phospholipase C, Na+- Ca2+ exchange, Ca2+ channels, Cl- channels, and K+ channels. The formation of calcium-mobilizing inositol phosphates can either be enhanced or inhibited. In general, adenosine has been found to act in concert with other hormones or neurotransmitters in either an inhibitory or a stimulatory way. The myriad modulatory actions of adenosine suggest that: 1) adenosine may simultaneously produce multiple effects within the same cell; and 2) activation of A1 receptors may lead to either a decrease or an increase in the coupling of other receptors to their G proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916091     DOI: 10.1096/fasebj.5.12.1916091

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  38 in total

1.  Glucose-induced intestinal vasodilation via adenosine A1 receptors requires nitric oxide but not K(+)(ATP) channels.

Authors:  Paul J Matheson; Na Li; Patrick D Harris; El Rasheid Zakaria; R Neal Garrison
Journal:  J Surg Res       Date:  2010-03-06       Impact factor: 2.192

2.  Adenosine 5'-monophosphate transport across the membrane of synaptosomes and myelin.

Authors:  R P Shank
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

3.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

4.  Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

Authors:  H O Kim; X D Ji; N Melman; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

5.  Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO.

Authors:  P Nieri; E Martinotti; V Calderone; M C Breschi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Intracellular cross-talk between thyrotropin receptor and A1 adenosine receptor in regulation of phospholipase C and adenylate cyclase in COS-7 cells transfected with their receptor genes.

Authors:  F Okajima; H Tomura; K Sho; M Akbar; M A Majid; Y Kondo
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat.

Authors:  J R Fozard; A M Carruthers
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Adenosine mediated desensitization of cAMP signaling enhances T-cell responses.

Authors:  Ailian Yang; Ashley D Mucsi; Melanie D Desrosiers; Jiang-Fan Chen; Jürgen B Schnermann; Michael R Blackburn; Yan Shi
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

9.  Cross-talk between muscarinic- and adenosine-receptor signalling in the regulation of cytosolic free Ca2+ and insulin secretion.

Authors:  T J Biden; C L Browne
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

10.  Contraction of the rat isolated spleen mediated by adenosine A1 receptor activation.

Authors:  J R Fozard; M Milavec-Krizman
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.